Sara Al Dallal: Transforming Hemophilia Care Across the Gulf
Sara Al Dallal, President of Emirates Health Economics Society at Emirates Medical Association, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Global Hematology, adding:
“Hemophilia care in the Gulf.
I’m pleased to share our new paper in Blood Global Hematology, ‘Transforming hemophilia care in the Gulf region: a patient journey and policy framework.’
Some numbers behind the case for action:
- Only approximatelly 42% of people with hemophilia are estimated to be diagnosed across the Eastern Mediterranean region.
- Reported prevalence ranges from 1.06 to 7.54 per 100,000 across the Gulf, largely reflecting differences in registration and diagnostics, not true disease burden.
- Estimated costs of hemophilia A in the MENA region reach up to $870,000 per patient per year.
Our multistakeholder panel of hematologists, policymakers and patient advocates mapped the journey from diagnosis to long-term care.
Our priorities for health systems:
- Hub-and-spoke centers of excellence. Saudi Arabia’s regional network led to a threefold increase in bleeding disorder detection.
- National registries to support forecasting, procurement and real-world evidence.
- Unified national and regional guidelines to reduce variability without heavy manpower demands.
- Real-world outcomes linked to reimbursement. Coordinated data could strengthen collective negotiating power, but it requires investment in interoperable digital infrastructure.
- Gulf-specific health economic evidence (budget impact, cost-utility, resource use).
As a health economist, I believe policy change happens when solutions are practical, quantifiable and easy to act on.”
Title: Transforming hemophilia care in the Gulf region: a patient journey and policy framework
Authors: Muhammad Faisal Khanani, Ahmed Abdelbari, Mohammad Fahed Abdullah, Sara Al Dallal, Shahrukh Hashmi, Ali Mullah-Ali, Tarek Owaidah, Nisrine Sabra, Dalal Badis, Nadia Steitieh, Johnny Mahlangu

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines